Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a new release version; no substantive changes to the displayed study information are evident.
    Difference
    0.1%
    Check dated 2026-05-17T10:14:31.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The page’s release/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a maintenance or platform update rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-04-25T18:52:01.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:45:53.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Version update from v3.4.3 to v3.5.0; study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.1%
    Check dated 2026-03-21T00:52:20.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision 3.4.3 was added and 3.4.2 was removed. No study details or interactive elements appear to be altered.
    Difference
    0.1%
    Check dated 2026-03-06T18:20:45.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 was removed. This appears to be a maintenance/version update that does not modify study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:22:38.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.